ID

39086

Descrição

Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01622439

Link

https://clinicaltrials.gov/show/NCT01622439

Palavras-chave

Versões (1)
  1. 29/11/2019 29/11/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

29 de novembro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Diffuse Large B-cell Lymphoma NCT01622439

Inglês

Eligibility Diffuse Large B-cell Lymphoma NCT01622439

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18-80 years
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
histologically confirmed (according to the who classification) diffuse large b-cell lymphoma stage ii-iv
Descrição

Diffuse Large B-Cell Lymphoma WHO tumor classification

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C1301142
no previous treatment for lymphoma. corticosteroids for alleviation of lymphoma associated symptoms are allowed
Descrição

Prior Therapy Absent Lymphoma | Adrenal Cortex Hormones Mitigation Intent allowed

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0024299
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1706602
UMLS CUI [2,3]
C0683607
who performance status 0-2
Descrição

WHO performance status scale

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1298650
hiv negativity
Descrição

HIV negative

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0481430
seronegativity for hcv, hbsag, anti-hbc, or other active infection uncontrolled by treatment
Descrição

Hepatitis C virus Seronegative | Hepatitis B Surface Antigens Seronegative | Anti-HBc antibody Seronegative | Infection Uncontrolled Seronegative

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0220847
UMLS CUI [1,2]
C0521144
UMLS CUI [2,1]
C0019168
UMLS CUI [2,2]
C0521144
UMLS CUI [3,1]
C0948759
UMLS CUI [3,2]
C0521144
UMLS CUI [4,1]
C3714514
UMLS CUI [4,2]
C0205318
UMLS CUI [4,3]
C0521144
absence of psychiatric illness or condition which could interfere with the subjects ability understand the requirements of the study
Descrição

Mental disorders Absent | Interference Comprehension Study Protocol

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0521102
UMLS CUI [2,2]
C0162340
UMLS CUI [2,3]
C2348563
absence of neurological or neuropsychiatric disorder, interfering with the requirements of the study
Descrição

Nervous system disorder Absent | Neuropsychiatric syndrome Absent | Interference Protocol Compliance

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0027765
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C3203509
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0521102
UMLS CUI [3,2]
C0525058
absence of hearing impairment > grade 2
Descrição

Absence Hearing impairment CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1384666
UMLS CUI [1,3]
C1516728
absence of porphyria
Descrição

Porphyria Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3463940
UMLS CUI [1,2]
C0332197
in females: absence of pregnancy and lactation
Descrição

Gender | Pregnancy Absent | Breast Feeding Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0006147
UMLS CUI [3,2]
C0332197
all subjects must agree to abstain from donating blood while taking study drug therapy and for one week following discontinuation of study drug therapy
Descrição

Blood Donation Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C0332197
all subjects must agree not to share study medication with another person, and to return all unused study drug to investigators
Descrição

Medication Sharing Absent | Investigational New Drugs Unused Return to Research Personnel

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0237876
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0445107
UMLS CUI [2,3]
C0332156
UMLS CUI [2,4]
C0035173
written informed concent according to ich/gcp and swedish regulations
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Voltar ao início da página

Similar models

Eligibility Diffuse Large B-cell Lymphoma NCT01622439

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18-80 years
boolean
C0001779 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma WHO tumor classification
Item
histologically confirmed (according to the who classification) diffuse large b-cell lymphoma stage ii-iv
boolean
C0079744 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
Prior Therapy Absent Lymphoma | Adrenal Cortex Hormones Mitigation Intent allowed
Item
no previous treatment for lymphoma. corticosteroids for alleviation of lymphoma associated symptoms are allowed
boolean
C1514463 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1706602 (UMLS CUI [2,2])
C0683607 (UMLS CUI [2,3])
WHO performance status scale
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
HIV negative
Item
hiv negativity
boolean
C0481430 (UMLS CUI [1])
Hepatitis C virus Seronegative | Hepatitis B Surface Antigens Seronegative | Anti-HBc antibody Seronegative | Infection Uncontrolled Seronegative
Item
seronegativity for hcv, hbsag, anti-hbc, or other active infection uncontrolled by treatment
boolean
C0220847 (UMLS CUI [1,1])
C0521144 (UMLS CUI [1,2])
C0019168 (UMLS CUI [2,1])
C0521144 (UMLS CUI [2,2])
C0948759 (UMLS CUI [3,1])
C0521144 (UMLS CUI [3,2])
C3714514 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0521144 (UMLS CUI [4,3])
Mental disorders Absent | Interference Comprehension Study Protocol
Item
absence of psychiatric illness or condition which could interfere with the subjects ability understand the requirements of the study
boolean
C0004936 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0521102 (UMLS CUI [2,1])
C0162340 (UMLS CUI [2,2])
C2348563 (UMLS CUI [2,3])
Nervous system disorder Absent | Neuropsychiatric syndrome Absent | Interference Protocol Compliance
Item
absence of neurological or neuropsychiatric disorder, interfering with the requirements of the study
boolean
C0027765 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3203509 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0521102 (UMLS CUI [3,1])
C0525058 (UMLS CUI [3,2])
Absence Hearing impairment CTCAE Grades
Item
absence of hearing impairment > grade 2
boolean
C0332197 (UMLS CUI [1,1])
C1384666 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Porphyria Absent
Item
absence of porphyria
boolean
C3463940 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Gender | Pregnancy Absent | Breast Feeding Absent
Item
in females: absence of pregnancy and lactation
boolean
C0079399 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Blood Donation Absent
Item
all subjects must agree to abstain from donating blood while taking study drug therapy and for one week following discontinuation of study drug therapy
boolean
C0005794 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Medication Sharing Absent | Investigational New Drugs Unused Return to Research Personnel
Item
all subjects must agree not to share study medication with another person, and to return all unused study drug to investigators
boolean
C0013227 (UMLS CUI [1,1])
C0237876 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0013230 (UMLS CUI [2,1])
C0445107 (UMLS CUI [2,2])
C0332156 (UMLS CUI [2,3])
C0035173 (UMLS CUI [2,4])
Informed Consent
Item
written informed concent according to ich/gcp and swedish regulations
boolean
C0021430 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial